Supersecretable peptids, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
Details for Australian Patent Application No. 2002247696 (hide)
International Classifications
Event Publications
27 February 2003 Application Open to Public Inspection
Published as AU-B-2002247696
15 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
12 October 2006 Application Accepted
Published as AU-B-2002247696
16 November 2006 Application for Amendment
The nature of the amendment is: Amend the invention title to read Use of supersecretable peptids in processes for their production and for parallel improvement of exported forms of one or more other polypeptides. Address for service in Australia - Watermark Patent & Trademark Attorneys The Glasshouse 290 Burwood Road Hawthorn VIC 3122
8 February 2007 Standard Patent Sealed
8 February 2007 Corrigenda
Amendments, Section 104 - Application for Amendments Under the name Sanofi-Aventis Deutschland GmbH, Application No. 2002247696, under INID (54) correct the title to read Use of supersecretable peptides in processes for their production and for parallel improvement of the exported forms of one or more other polypeptides
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser